Compare MEI & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEI | EOLS |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 581.1M | 500.0M |
| IPO Year | 1994 | 2018 |
| Metric | MEI | EOLS |
|---|---|---|
| Price | $14.56 | $7.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $22.00 | $15.00 |
| AVG Volume (30 Days) | 550.3K | ★ 611.3K |
| Earning Date | 12-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | ★ 42.94 | 1.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $908,300,000.00 | $297,176,000.00 |
| Revenue This Year | $4.13 | $12.44 |
| Revenue Next Year | $5.76 | $17.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 11.24 | ★ 11.61 |
| 52 Week Low | $4.88 | $3.86 |
| 52 Week High | $20.38 | $9.31 |
| Indicator | MEI | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 50.48 | 44.23 |
| Support Level | $13.22 | $7.07 |
| Resistance Level | $15.75 | $7.83 |
| Average True Range (ATR) | 1.01 | 0.32 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 50.69 | 44.17 |
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, with the majority of revenue from Europe, the Middle East & Africa (EMEA).
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.